Come up with a name for your new list and we'll add to it:
Velabs Therapeutics raised a round of funding on January 01, 2017. Investors include
European Molecular Biology Laboratory.
Velabs Therapeutics specializes in microfluidics-based screening technology and applications. The company's droplet-based microfluidic screening technology aims at the fast generation of antibodies ag…